Blocklisting Application

RNS Number : 3595B
Craneware plc
11 February 2022
 

 

Craneware plc

("Craneware" or the "Company")

 

 

Blocklisting Application

 

Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market,   announces that a block listing application has been made to the London Stock Exchange for 200,000 ordinary shares of one pence each ("Ordinary Shares") to be admitted to trading on AIM (the "Admission").  The Ordinary Shares that are being reserved under this block listing application will be issued by the Company, as required, in order to satisfy the exercise of share options pursuant to the terms of the following share plans:

 

Share plan

Number of Ordinary Shares

The Craneware plc SAYE Option Plan (2018)

100,000

The Craneware plc Employee Stock Purchase Plan (2018)

100,000



Total

200,000

 

 

It is expected that Admission of these Ordinary Shares will become effective on 16 February 2022. When issued, the Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.

 

 

  For further information, please contact:

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO


Craig Preston, CFO




Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Hilary Buchanan, Joe Pederzolli

craneware@almapr.co.uk



Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Dan Webster, Andrew Clark, Lalit Bose




Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Sebastian Lawrence


   

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff


 

About Craneware

 

We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.

 

Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.

 

Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 2000 U.S hospitals and health systems and almost 10,000 clinics and retail pharmacies. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

 

Learn more at craneware.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSGPUWGPUPPGRU

Companies

Craneware (CRW)
UK 100

Latest directors dealings